B
Biopharmaceutical Research
Pharmaceutical manufacturing and analytical firm focused on the production of cannabis for researchers across the United States and the USDA-compliant THC testing of hemp
About Biopharmaceutical Research
Biopharma Research Co. (BRC) is a fully integrated, federally legal cannabis research, development, and production company. Operating within the pharmaceutical sector, BRC specializes in developing federally compliant active pharmaceutical ingredients (APIs) for plant-based therapeutics. The company serves a diverse range of clients including researchers, academic institutions, and DEA registrants across nearly a dozen states. BRC's mission is to deliver uncompromising quality in its products, which are produced in an indoor, cGMP compliant facility located in a highly secure area within an underserved community in the United States. The company supports Investigational New Drug (IND) applications for researchers focused on treatments for PTSD, chronic pain, and other conditions. BRC generates revenue through the sale of its high-quality APIs to various stakeholders in the pharmaceutical and research sectors.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2022 | $20M | $116M | Argonautic Ventures · Delta Emerald Ventures · Achari Ventures · AFI Capital Partners | ↗ |
Growth signals
Latest recorded traffic for Biopharmaceutical Research is 1.3K monthly website visits, up 39.8% over the last three months. Biopharmaceutical Research's team grew 4.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Biopharmaceutical Research in the Castroville ecosystem
The Biopharmaceutical Research office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A6 investors entered at this stage
- IPIntrinsic Capital Partners
Argonautic Ventures- DVDelta Emerald Ventures
Achari Ventures
AFI Capital Partners
Self Health America Holdings
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Biopharmaceutical Research on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Biopharmaceutical Research’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









